CRISPR Market Report

Global CRISPR Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 27, 2022
  • PAGES：208
  • REPORT CODE：GMM816432
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • CRISPR (clustered regularly interspaced short palindromic repeats) is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes.

    CRISPR market report explains the definition, types, applications, major countries, and major players of the CRISPR market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Cellectis

    • Danaher Corporation

    • Caribou Biosciences, Inc

    • Lonza

    • Genscript

    • F Hoffmann-La Roche Ltd

    • Addgene

    • Egenesis

    • Editas Medicine, Inc

    • AstraZeneca

    • Horizon Discovery Group Plc

    • Intellia Therapeutics, Inc

    By Type:

    • Enzymes

    • Kits and Reagents

    • Guide RNA

    • Others

    By End-User:

    • Biomedical

    • Agricultural

    • Industrial

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global CRISPR Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 CRISPR Outlook to 2028- Original Forecasts

    • 2.2 CRISPR Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term CRISPR Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global CRISPR Market- Recent Developments

    • 6.1 CRISPR Market News and Developments

    • 6.2 CRISPR Market Deals Landscape

    7 CRISPR Raw Materials and Cost Structure Analysis

    • 7.1 CRISPR Key Raw Materials

    • 7.2 CRISPR Price Trend of Key Raw Materials

    • 7.3 CRISPR Key Suppliers of Raw Materials

    • 7.4 CRISPR Market Concentration Rate of Raw Materials

    • 7.5 CRISPR Cost Structure Analysis

      • 7.5.1 CRISPR Raw Materials Analysis

      • 7.5.2 CRISPR Labor Cost Analysis

      • 7.5.3 CRISPR Manufacturing Expenses Analysis

    8 Global CRISPR Import and Export Analysis (Top 10 Countries)

    • 8.1 Global CRISPR Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global CRISPR Export by Region (Top 10 Countries) (2017-2028)

    9 Global CRISPR Market Outlook by Types and Applications to 2022

    • 9.1 Global CRISPR Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Enzymes Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Kits and Reagents Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Guide RNA Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global CRISPR Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Biomedical Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Agricultural Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Industrial Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise CRISPR Market Analysis and Outlook till 2022

    • 10.1 Global CRISPR Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States CRISPR Consumption (2017-2022)

      • 10.2.2 Canada CRISPR Consumption (2017-2022)

      • 10.2.3 Mexico CRISPR Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany CRISPR Consumption (2017-2022)

      • 10.3.2 UK CRISPR Consumption (2017-2022)

      • 10.3.3 Spain CRISPR Consumption (2017-2022)

      • 10.3.4 Belgium CRISPR Consumption (2017-2022)

      • 10.3.5 France CRISPR Consumption (2017-2022)

      • 10.3.6 Italy CRISPR Consumption (2017-2022)

      • 10.3.7 Denmark CRISPR Consumption (2017-2022)

      • 10.3.8 Finland CRISPR Consumption (2017-2022)

      • 10.3.9 Norway CRISPR Consumption (2017-2022)

      • 10.3.10 Sweden CRISPR Consumption (2017-2022)

      • 10.3.11 Poland CRISPR Consumption (2017-2022)

      • 10.3.12 Russia CRISPR Consumption (2017-2022)

      • 10.3.13 Turkey CRISPR Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China CRISPR Consumption (2017-2022)

      • 10.4.2 Japan CRISPR Consumption (2017-2022)

      • 10.4.3 India CRISPR Consumption (2017-2022)

      • 10.4.4 South Korea CRISPR Consumption (2017-2022)

      • 10.4.5 Pakistan CRISPR Consumption (2017-2022)

      • 10.4.6 Bangladesh CRISPR Consumption (2017-2022)

      • 10.4.7 Indonesia CRISPR Consumption (2017-2022)

      • 10.4.8 Thailand CRISPR Consumption (2017-2022)

      • 10.4.9 Singapore CRISPR Consumption (2017-2022)

      • 10.4.10 Malaysia CRISPR Consumption (2017-2022)

      • 10.4.11 Philippines CRISPR Consumption (2017-2022)

      • 10.4.12 Vietnam CRISPR Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil CRISPR Consumption (2017-2022)

      • 10.5.2 Colombia CRISPR Consumption (2017-2022)

      • 10.5.3 Chile CRISPR Consumption (2017-2022)

      • 10.5.4 Argentina CRISPR Consumption (2017-2022)

      • 10.5.5 Venezuela CRISPR Consumption (2017-2022)

      • 10.5.6 Peru CRISPR Consumption (2017-2022)

      • 10.5.7 Puerto Rico CRISPR Consumption (2017-2022)

      • 10.5.8 Ecuador CRISPR Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain CRISPR Consumption (2017-2022)

      • 10.6.2 Kuwait CRISPR Consumption (2017-2022)

      • 10.6.3 Oman CRISPR Consumption (2017-2022)

      • 10.6.4 Qatar CRISPR Consumption (2017-2022)

      • 10.6.5 Saudi Arabia CRISPR Consumption (2017-2022)

      • 10.6.6 United Arab Emirates CRISPR Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria CRISPR Consumption (2017-2022)

      • 10.7.2 South Africa CRISPR Consumption (2017-2022)

      • 10.7.3 Egypt CRISPR Consumption (2017-2022)

      • 10.7.4 Algeria CRISPR Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia CRISPR Consumption (2017-2022)

      • 10.8.2 New Zealand CRISPR Consumption (2017-2022)

    11 Global CRISPR Competitive Analysis

    • 11.1 Cellectis

      • 11.1.1 Cellectis Company Details

      • 11.1.2 Cellectis CRISPR Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Cellectis CRISPR Main Business and Markets Served

      • 11.1.4 Cellectis CRISPR Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Danaher Corporation

      • 11.2.1 Danaher Corporation Company Details

      • 11.2.2 Danaher Corporation CRISPR Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Danaher Corporation CRISPR Main Business and Markets Served

      • 11.2.4 Danaher Corporation CRISPR Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Caribou Biosciences, Inc

      • 11.3.1 Caribou Biosciences, Inc Company Details

      • 11.3.2 Caribou Biosciences, Inc CRISPR Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Caribou Biosciences, Inc CRISPR Main Business and Markets Served

      • 11.3.4 Caribou Biosciences, Inc CRISPR Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Lonza

      • 11.4.1 Lonza Company Details

      • 11.4.2 Lonza CRISPR Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Lonza CRISPR Main Business and Markets Served

      • 11.4.4 Lonza CRISPR Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Genscript

      • 11.5.1 Genscript Company Details

      • 11.5.2 Genscript CRISPR Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Genscript CRISPR Main Business and Markets Served

      • 11.5.4 Genscript CRISPR Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 F Hoffmann-La Roche Ltd

      • 11.6.1 F Hoffmann-La Roche Ltd Company Details

      • 11.6.2 F Hoffmann-La Roche Ltd CRISPR Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 F Hoffmann-La Roche Ltd CRISPR Main Business and Markets Served

      • 11.6.4 F Hoffmann-La Roche Ltd CRISPR Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Addgene

      • 11.7.1 Addgene Company Details

      • 11.7.2 Addgene CRISPR Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Addgene CRISPR Main Business and Markets Served

      • 11.7.4 Addgene CRISPR Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Egenesis

      • 11.8.1 Egenesis Company Details

      • 11.8.2 Egenesis CRISPR Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Egenesis CRISPR Main Business and Markets Served

      • 11.8.4 Egenesis CRISPR Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Editas Medicine, Inc

      • 11.9.1 Editas Medicine, Inc Company Details

      • 11.9.2 Editas Medicine, Inc CRISPR Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Editas Medicine, Inc CRISPR Main Business and Markets Served

      • 11.9.4 Editas Medicine, Inc CRISPR Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 AstraZeneca

      • 11.10.1 AstraZeneca Company Details

      • 11.10.2 AstraZeneca CRISPR Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 AstraZeneca CRISPR Main Business and Markets Served

      • 11.10.4 AstraZeneca CRISPR Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Horizon Discovery Group Plc

      • 11.11.1 Horizon Discovery Group Plc Company Details

      • 11.11.2 Horizon Discovery Group Plc CRISPR Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Horizon Discovery Group Plc CRISPR Main Business and Markets Served

      • 11.11.4 Horizon Discovery Group Plc CRISPR Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Intellia Therapeutics, Inc

      • 11.12.1 Intellia Therapeutics, Inc Company Details

      • 11.12.2 Intellia Therapeutics, Inc CRISPR Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Intellia Therapeutics, Inc CRISPR Main Business and Markets Served

      • 11.12.4 Intellia Therapeutics, Inc CRISPR Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    12 Global CRISPR Market Outlook by Types and Applications to 2028

    • 12.1 Global CRISPR Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Enzymes Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Kits and Reagents Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Guide RNA Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global CRISPR Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Biomedical Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Agricultural Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Industrial Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise CRISPR Market Analysis and Outlook to 2028

    • 13.1 Global CRISPR Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States CRISPR Consumption Forecast (2022-2028)

      • 13.2.2 Canada CRISPR Consumption Forecast (2022-2028)

      • 13.2.3 Mexico CRISPR Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany CRISPR Consumption Forecast (2022-2028)

      • 13.3.2 UK CRISPR Consumption Forecast (2022-2028)

      • 13.3.3 Spain CRISPR Consumption Forecast (2022-2028)

      • 13.3.4 Belgium CRISPR Consumption Forecast (2022-2028)

      • 13.3.5 France CRISPR Consumption Forecast (2022-2028)

      • 13.3.6 Italy CRISPR Consumption Forecast (2022-2028)

      • 13.3.7 Denmark CRISPR Consumption Forecast (2022-2028)

      • 13.3.8 Finland CRISPR Consumption Forecast (2022-2028)

      • 13.3.9 Norway CRISPR Consumption Forecast (2022-2028)

      • 13.3.10 Sweden CRISPR Consumption Forecast (2022-2028)

      • 13.3.11 Poland CRISPR Consumption Forecast (2022-2028)

      • 13.3.12 Russia CRISPR Consumption Forecast (2022-2028)

      • 13.3.13 Turkey CRISPR Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China CRISPR Consumption Forecast (2022-2028)

      • 13.4.2 Japan CRISPR Consumption Forecast (2022-2028)

      • 13.4.3 India CRISPR Consumption Forecast (2022-2028)

      • 13.4.4 South Korea CRISPR Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan CRISPR Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh CRISPR Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia CRISPR Consumption Forecast (2022-2028)

      • 13.4.8 Thailand CRISPR Consumption Forecast (2022-2028)

      • 13.4.9 Singapore CRISPR Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia CRISPR Consumption Forecast (2022-2028)

      • 13.4.11 Philippines CRISPR Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam CRISPR Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil CRISPR Consumption Forecast (2022-2028)

      • 13.5.2 Colombia CRISPR Consumption Forecast (2022-2028)

      • 13.5.3 Chile CRISPR Consumption Forecast (2022-2028)

      • 13.5.4 Argentina CRISPR Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela CRISPR Consumption Forecast (2022-2028)

      • 13.5.6 Peru CRISPR Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico CRISPR Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador CRISPR Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain CRISPR Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait CRISPR Consumption Forecast (2022-2028)

      • 13.6.3 Oman CRISPR Consumption Forecast (2022-2028)

      • 13.6.4 Qatar CRISPR Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia CRISPR Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates CRISPR Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria CRISPR Consumption Forecast (2022-2028)

      • 13.7.2 South Africa CRISPR Consumption Forecast (2022-2028)

      • 13.7.3 Egypt CRISPR Consumption Forecast (2022-2028)

      • 13.7.4 Algeria CRISPR Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia CRISPR Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand CRISPR Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of CRISPR

    • Figure of CRISPR Picture

    • Table Global CRISPR Import by Region (Top 10 Countries) (2017-2028)

    • Table Global CRISPR Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Enzymes Consumption and Growth Rate (2017-2022)

    • Figure Global Kits and Reagents Consumption and Growth Rate (2017-2022)

    • Figure Global Guide RNA Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Biomedical Consumption and Growth Rate (2017-2022)

    • Figure Global Agricultural Consumption and Growth Rate (2017-2022)

    • Figure Global Industrial Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global CRISPR Consumption by Country (2017-2022)

    • Table North America CRISPR Consumption by Country (2017-2022)

    • Figure United States CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Canada CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Mexico CRISPR Consumption and Growth Rate (2017-2022)

    • Table Europe CRISPR Consumption by Country (2017-2022)

    • Figure Germany CRISPR Consumption and Growth Rate (2017-2022)

    • Figure UK CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Spain CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Belgium CRISPR Consumption and Growth Rate (2017-2022)

    • Figure France CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Italy CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Denmark CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Finland CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Norway CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Sweden CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Poland CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Russia CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Turkey CRISPR Consumption and Growth Rate (2017-2022)

    • Table APAC CRISPR Consumption by Country (2017-2022)

    • Figure China CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Japan CRISPR Consumption and Growth Rate (2017-2022)

    • Figure India CRISPR Consumption and Growth Rate (2017-2022)

    • Figure South Korea CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Pakistan CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Indonesia CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Thailand CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Singapore CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Malaysia CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Philippines CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Vietnam CRISPR Consumption and Growth Rate (2017-2022)

    • Table South America CRISPR Consumption by Country (2017-2022)

    • Figure Brazil CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Colombia CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Chile CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Argentina CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Venezuela CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Peru CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Ecuador CRISPR Consumption and Growth Rate (2017-2022)

    • Table GCC CRISPR Consumption by Country (2017-2022)

    • Figure Bahrain CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Kuwait CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Oman CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Qatar CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia CRISPR Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates CRISPR Consumption and Growth Rate (2017-2022)

    • Table Africa CRISPR Consumption by Country (2017-2022)

    • Figure Nigeria CRISPR Consumption and Growth Rate (2017-2022)

    • Figure South Africa CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Egypt CRISPR Consumption and Growth Rate (2017-2022)

    • Figure Algeria CRISPR Consumption and Growth Rate (2017-2022)

    • Table Oceania CRISPR Consumption by Country (2017-2022)

    • Figure Australia CRISPR Consumption and Growth Rate (2017-2022)

    • Figure New Zealand CRISPR Consumption and Growth Rate (2017-2022)

    • Table Cellectis Company Details

    • Table Cellectis CRISPR Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cellectis CRISPR Main Business and Markets Served

    • Table Cellectis CRISPR Product Portfolio

    • Table Danaher Corporation Company Details

    • Table Danaher Corporation CRISPR Sales, Price, Value and Gross Profit (2017-2022)

    • Table Danaher Corporation CRISPR Main Business and Markets Served

    • Table Danaher Corporation CRISPR Product Portfolio

    • Table Caribou Biosciences, Inc Company Details

    • Table Caribou Biosciences, Inc CRISPR Sales, Price, Value and Gross Profit (2017-2022)

    • Table Caribou Biosciences, Inc CRISPR Main Business and Markets Served

    • Table Caribou Biosciences, Inc CRISPR Product Portfolio

    • Table Lonza Company Details

    • Table Lonza CRISPR Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lonza CRISPR Main Business and Markets Served

    • Table Lonza CRISPR Product Portfolio

    • Table Genscript Company Details

    • Table Genscript CRISPR Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genscript CRISPR Main Business and Markets Served

    • Table Genscript CRISPR Product Portfolio

    • Table F Hoffmann-La Roche Ltd Company Details

    • Table F Hoffmann-La Roche Ltd CRISPR Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd CRISPR Main Business and Markets Served

    • Table F Hoffmann-La Roche Ltd CRISPR Product Portfolio

    • Table Addgene Company Details

    • Table Addgene CRISPR Sales, Price, Value and Gross Profit (2017-2022)

    • Table Addgene CRISPR Main Business and Markets Served

    • Table Addgene CRISPR Product Portfolio

    • Table Egenesis Company Details

    • Table Egenesis CRISPR Sales, Price, Value and Gross Profit (2017-2022)

    • Table Egenesis CRISPR Main Business and Markets Served

    • Table Egenesis CRISPR Product Portfolio

    • Table Editas Medicine, Inc Company Details

    • Table Editas Medicine, Inc CRISPR Sales, Price, Value and Gross Profit (2017-2022)

    • Table Editas Medicine, Inc CRISPR Main Business and Markets Served

    • Table Editas Medicine, Inc CRISPR Product Portfolio

    • Table AstraZeneca Company Details

    • Table AstraZeneca CRISPR Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca CRISPR Main Business and Markets Served

    • Table AstraZeneca CRISPR Product Portfolio

    • Table Horizon Discovery Group Plc Company Details

    • Table Horizon Discovery Group Plc CRISPR Sales, Price, Value and Gross Profit (2017-2022)

    • Table Horizon Discovery Group Plc CRISPR Main Business and Markets Served

    • Table Horizon Discovery Group Plc CRISPR Product Portfolio

    • Table Intellia Therapeutics, Inc Company Details

    • Table Intellia Therapeutics, Inc CRISPR Sales, Price, Value and Gross Profit (2017-2022)

    • Table Intellia Therapeutics, Inc CRISPR Main Business and Markets Served

    • Table Intellia Therapeutics, Inc CRISPR Product Portfolio

    • Figure Global Enzymes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Kits and Reagents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Guide RNA Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biomedical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Agricultural Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Industrial Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CRISPR Consumption Forecast by Country (2022-2028)

    • Table North America CRISPR Consumption Forecast by Country (2022-2028)

    • Figure United States CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe CRISPR Consumption Forecast by Country (2022-2028)

    • Figure Germany CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure France CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC CRISPR Consumption Forecast by Country (2022-2028)

    • Figure China CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure India CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Table South America CRISPR Consumption Forecast by Country (2022-2028)

    • Figure Brazil CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC CRISPR Consumption Forecast by Country (2022-2028)

    • Figure Bahrain CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa CRISPR Consumption Forecast by Country (2022-2028)

    • Figure Nigeria CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania CRISPR Consumption Forecast by Country (2022-2028)

    • Figure Australia CRISPR Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand CRISPR Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US